Table of Contents Table of Contents
Previous Page  9 / 52 Next Page
Information
Show Menu
Previous Page 9 / 52 Next Page
Page Background

Median OS, mo

(95% CI)

HR

(97.73% CI)

P

-value

Nivolumab (n = 240)

7.5 (5.5, 9.1)

0.70

(0.51, 0.96)

0.0101

Investigator’s Choice (n = 121)

5.1 (4.0, 6.0)

Overall Survival

9

Months

Nivolumab

240

167

109

52

24

7

0

Investigator’s

Choice

121

87

42

17

5

1

No. at Risk

0

Overall Survival (% of patients)

0

3

6

9

12

15

18

0

10

20

30

40

50

60

70

80

90

100

1-year OS rate (95% CI)

36.0%

(28.5, 43.4)

16.6%

(8.6, 26.8)